Comparison of HLA phenotypes in long-term survivors with acute lymphoblastic leukemia treated with immunotherapy versus chemotherapy.
作者信息
Tursz T, Hors J, Lipinski M, Amiel J L, Mathé G
出版信息
Recent Results Cancer Res. 1982;80:26-8. doi: 10.1007/978-3-642-81685-7_5.
PMID:7036290
Abstract
摘要
相似文献
1
Comparison of HLA phenotypes in long-term survivors with acute lymphoblastic leukemia treated with immunotherapy versus chemotherapy.接受免疫疗法与化疗的急性淋巴细胞白血病长期存活者的HLA表型比较。
Recent Results Cancer Res. 1982;80:26-8. doi: 10.1007/978-3-642-81685-7_5.
2
[HLA phenotypes in patients surviving a long time after immunotherapy with BCG for acute childhood lymphoblastic leukemia. Arguments in favor of the existance of a gene for immune response in human leukemia].[卡介苗免疫治疗急性儿童淋巴细胞白血病后长期存活患者的HLA表型。支持人类白血病中存在免疫反应基因的论据]
C R Acad Hebd Seances Acad Sci D. 1977 Dec 19;285(16):1585-7.
3
HLA phenotypes in long-term survivors treated with BCG immunotherapy for childhood ALL.接受卡介苗免疫疗法治疗儿童急性淋巴细胞白血病的长期存活者的人类白细胞抗原表型
Br Med J. 1978 May 13;1(6122):1250-1. doi: 10.1136/bmj.1.6122.1250-a.
4
Active immunotherapy for acute lymphoblastic leukaemia.急性淋巴细胞白血病的主动免疫疗法。
Lancet. 1969 Apr 5;1(7597):697-9. doi: 10.1016/s0140-6736(69)92648-8.
5
HLA-A and HLA-B antigens in acute leukemia: A2--B12 phenotypes correlate with longer survival in acute myelogenous leukemia.
Acta Haematol. 1981;65(2):73-8. doi: 10.1159/000207154.
6
Immunotherapy in previously treated acute lymphatic leukemia.既往接受过治疗的急性淋巴细胞白血病的免疫治疗
Natl Cancer Inst Monogr. 1973 Dec;39:177-87.
7
HLA haplotypes and long survival in childhood acute lymphoblastic leukaemia treated with transfer factor.HLA单倍型与接受转移因子治疗的儿童急性淋巴细胞白血病的长期存活
Br J Haematol. 1980 Feb;44(2):243-51. doi: 10.1111/j.1365-2141.1980.tb01206.x.
8
The place of immunological methods of treatment in the management of acute leukaemia.免疫治疗方法在急性白血病治疗中的地位。
Hamatol Bluttransfus. 1976;19:297-304. doi: 10.1007/978-3-642-87524-3_31.
9
Increase in "Null" cells in acute lymphocytic leukaemia in remission on long-term immunotherapy.长期免疫治疗缓解期急性淋巴细胞白血病中“无功能”细胞增加。
Br J Cancer. 1976 May;33(5):567-70. doi: 10.1038/bjc.1976.91.
10
BCG in cancer immunotherapy: experimental and clinical trials of its use in treatment of leukemia minimal and or residual disease.
Natl Cancer Inst Monogr. 1973 Dec;39:165-75.
引用本文的文献
1
HLA-A2 antigen status predicts metastasis and response to immunotherapy in gastric cancer.人类白细胞抗原A2（HLA-A2）抗原状态可预测胃癌的转移及对免疫治疗的反应。
Cancer Immunol Immunother. 1997 Oct;45(1):53-9. doi: 10.1007/s002620050400.
Zotero 插件